NewsTalk 1290 KOIL Huskers New data shows Alzheimer's drug can slow cognitive decline Nebraska Cornhuskers • Nov 30, 2022
KGFW Kearney New data shows Alzheimer's drug can slow cognitive decline Frontier Trails • Nov 30, 2022
Columbus Telegram Business Drug slows Alzheimer's but can it make a real difference? Nebraska Business • Nov 30, 2022
Columbus Telegram Business Biogen tabs veteran pharma leader Viehbacher as next CEO Nebraska Business • Nov 10, 2022
Columbus Telegram Business Alzheimer's drug shows promise in early results of study Nebraska Business • Sep 28, 2022
Columbus Telegram Business Biogen pays $900M to settle doctor kickback allegations Nebraska Business • Sep 27, 2022
Columbus Telegram Business Change at the top for Biogen after Alzheimer's drug flops Nebraska Business • May 3, 2022
North Platte Telegraph The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm Prairie Lakes • Apr 14, 2022
Columbus Telegram The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm Lewis & Clark • Apr 14, 2022
The Grand Island Independent The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm Frontier Trails • Apr 14, 2022
Omaha World Herald | Metro News The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm Nebraska Metro • Apr 14, 2022
Columbus Telegram Business Biogen's 2022 outlook leaves investors wanting, shares slip Nebraska Business • Feb 3, 2022
Columbus Telegram Business Biogen tumbles after Medicare lays out Aduhelm coverage plan Nebraska Business • Jan 13, 2022
KLIN Radio Lincoln Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug Nebraska Metro • Oct 20, 2021
Columbus Telegram Business Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug Nebraska Business • Oct 20, 2021
Daily Mail on Nebraska Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen Nebraska Non-Local Sources • Aug 16, 2021
The Grand Island Independent FDA's Alzheimer's mistake already worsening Frontier Trails • Jul 14, 2021
The Grand Island Independent Doctors shouldn't get rich from unproven Alzheimer's drug Frontier Trails • Jun 21, 2021
KLIN Radio Lincoln FDA set to rule on controversial Biogen Alzheimer's drug Nebraska Metro • Jun 7, 2021
Nebraska Fence Post Ogallala Biogenic CO2 Coalition urges Congress to monitor EPA rule Prairie Lakes • May 12, 2020
Daily Mail on Nebraska Buffett's Berkshire buys Kroger and Biogen, reduces Wells Fargo and Goldman stakes Nebraska Non-Local Sources • Feb 14, 2020
Nebraska AG Connection Ag State Colleagues Call for Biogenic Carbon Emission Clarity Nebraska Business • Nov 20, 2019
Columbus Telegram Business How Biogen Salvaged Its Alzheimer's Drug After a Costly Failure Nebraska Business • Oct 23, 2019